India's medical technology market is set for explosive growth, projected to expand from $15.2 billion in 2025 to $50.1 billion by 2030, according to industry estimates. Government initiatives aimed at strengthening domestic manufacturing and reducing reliance on imported medical devices are creating a favorable environment for local innovators. Among the companies poised to benefit is SS Innovations International (NASDAQ: SSII), which has developed a proprietary surgical robotic system, the SSi Mantra, designed to make robotic surgery more affordable and accessible.
As of June 30, 2026, SS Innovations reported 224 installations of its SSi Mantra system across 12 countries, with those systems used in more than 12,000 surgeries. The company also posted strong first-half 2026 financials, including 65.6% year-over-year revenue growth to $25.0 million and a 77.5% increase in gross profit. These figures underscore the growing adoption of the SSi Mantra platform and the company's ability to scale in a competitive global market.
Beyond expanding installations, SS Innovations has been developing long-distance telesurgery capabilities, which could extend the reach of specialized surgical care to remote areas. The company is also pursuing U.S. FDA clearance and European CE marking to enable broader international commercialization. Such regulatory milestones would open doors to major markets and further validate the technology.
The importance of this story lies in the intersection of healthcare and manufacturing policy. India's push to become a global hub for medical device production could reduce costs and improve access to advanced surgical care. For investors, SS Innovations offers exposure to a high-growth medtech segment with a proven product and expanding footprint. The company's focus on affordability and accessibility differentiates it from larger competitors, potentially capturing market share in emerging economies.
For more details, the full article is available at https://ibn.fm/Lb9Mw. The latest news and updates relating to SSII can be found in the company's newsroom at https://ibn.fm/SSII.
MissionIR, a specialized communications platform, assists IR firms with syndicated content to enhance visibility. It is part of the Dynamic Brand Portfolio at IBN, which provides wire solutions via InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions.
